129 related articles for article (PubMed ID: 6154661)
1. Modulation of target cell susceptibility to human natural killer cells by interferon.
Moore M; White WJ; Potter MR
Int J Cancer; 1980 May; 25(5):565-72. PubMed ID: 6154661
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human natural cell-mediated cytotoxicity by interferon.
Moore M; Potter MR
Br J Cancer; 1980 Mar; 41(3):378-87. PubMed ID: 6155926
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
6. Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Orn A; Wigzell H
Int J Cancer; 1981 Oct; 28(4):459-68. PubMed ID: 6171529
[TBL] [Abstract][Full Text] [Related]
7. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
9. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
Helfand SL; Werkmeister J; Roder JC
J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
[TBL] [Abstract][Full Text] [Related]
10. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
Yanovich S; Hall RE; Weinert C
Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
12. Naturally cytotoxic tonsillar lymphocytes: a manifestation of heterogeneity among human NK cells.
Kimber I; Moore M
Scand J Immunol; 1983 Jan; 17(1):29-36. PubMed ID: 6189181
[TBL] [Abstract][Full Text] [Related]
13. Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitro.
Biron CA; Hutt-Fletcher LM; Wertz GT; Pagano JS
Int J Cancer; 1981 Feb; 27(2):185-90. PubMed ID: 6169656
[TBL] [Abstract][Full Text] [Related]
14. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
Lee SH; Kelley S; Chiu H; Stebbing N
Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
[TBL] [Abstract][Full Text] [Related]
16. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of NK, but not K cell activity by different interferons.
Rumpold H; Kraft D; Scheiner O; Meindl P; Bodo G
Int Arch Allergy Appl Immunol; 1980; 62(2):152-61. PubMed ID: 6154652
[TBL] [Abstract][Full Text] [Related]
18. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
20. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
